GRISOVIN griseofulvin 500 mg tablet blister pack Australia - Inggris - Department of Health (Therapeutic Goods Administration)

grisovin griseofulvin 500 mg tablet blister pack

aspen pharmacare australia pty ltd - griseofulvin, quantity: 500 mg - tablet - excipient ingredients: sodium lauryl sulfate; povidone; maize starch; potato starch; microcrystalline cellulose; magnesium stearate - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Griseofulvin Tablets 125mg Malta - Inggris - Medicines Authority

griseofulvin tablets 125mg

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - griseofulvin - tablet - griseofulvin 125 mg - antifungals for dermatological use

Griseofulvin 125mg Tablets Malta - Inggris - Medicines Authority

griseofulvin 125mg tablets

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - griseofulvin - tablet - griseofulvin 125 mg - antifungals for dermatological use

GRISOFULVIN suspension Amerika Serikat - Inggris - NLM (National Library of Medicine)

grisofulvin suspension

cipla usa inc. - griseofulvin (unii: 32hrv3e3d5) (griseofulvin - unii:32hrv3e3d5) - griseofulvin oral suspension is indicated for the treatment of dermatophyte infections of the skin not adequately treated by topical therapy, hair and nails, namely: tinea corporis tinea pedis tinea cruris tinea barbae tinea capitis tinea unguium when caused by one or more of the following species of fungi: epidermophyton floccosum microsporum audouinii microsporum canis microsporum gypseum trichophyton crateriformis trichophyton gallinae trichophyton interdigitalis trichophyton megnini trichophyton mentagrophytes trichophyton rubrum trichophyton schoenleini trichophyton sulphureum trichophyton tonsurans trichophyton verrucosum note: prior to therapy, a dermatophyte should be identified as responsible for the infection. prior to initiating treatment, appropriate specimens for laboratory testing (koh preparation, fungal culture, or nail biopsy) should be obtained to confirm the diagnosis. griseofulvin is not effective in the following: bacterial infections                             coccidioidomycosis candid

GRISOVIN griseofulvin 125 mg tablet bottle Australia - Inggris - Department of Health (Therapeutic Goods Administration)

grisovin griseofulvin 125 mg tablet bottle

aspen pharmacare australia pty ltd - griseofulvin, quantity: 125 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; sodium lauryl sulfate; potato starch; magnesium stearate - indications as at 7 august 2001 : griseofulvin is indicated in the treatment of fungal infections of the skin, scalp, hair or nails, where topical therapy is considered innappropriate or has failed. when griseofulvin is given orally for systemic treatment of fungal infections, it enables newly formed keratin of the skin, hair and nails to resist attack by the fungi. as the new keratin extends, the old infected keratin is shed.

Griseofulvin Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

griseofulvin

origen pharmaceuticals limited - griseofulvin - tablet - 125mg, 500mg - active: griseofulvin